Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole.

Suppr

超能文献

作者信息

Benade L, Howard T, Burk D

出版信息

Oncology. 1969;23(1):33-43. doi: 10.1159/000224465.

DOI:10.1159/000224465

PMID:5774953

Abstract

摘要

相似文献

Synergistic killing of Ehrlich ascites carcinoma cells by ascorbate and 3-amino-1,2,4,-triazole.

Oncology. 1969;23(1):33-43. doi: 10.1159/000224465.

[Selective in vivo thermosensitization and therapy of the Ehrlich-mouse-ascites carcinoma with vitamin K 3 sodium bisulfite].

Dtsch Gesundheitsw. 1967 Oct 5;22(40):1879-85.

[Formation of CO 2 from C 1 metabolism in ascites tumor cells].

Acta Biol Med Ger. 1971;27(3):459-76.

[In vitro thermosensitization of Ehrlich mouse ascites Krebs cells by vitamin K3 and K5. Series of measurements on variation of the essential parameters as basis for the in vivo situation].

Z Naturforsch B. 1967 Apr;22(4):422-35.

Factors of Ehrlich Ascites Tumor resistance to oxidative stress.

Acta Physiol Pharmacol Bulg. 1995;21(3):49-55.

Enhancement of antitumor activity of ascorbate against Ehrlich ascites tumor cells by the copper:glycylglycylhistidine complex.

Cancer Res. 1983 Feb;43(2):824-8.

Hydrogen peroxide mediates the killing of U937 tumor cells elicited by pharmacologically attainable concentrations of ascorbic acid: cell death prevention by extracellular catalase or catalase from cocultured erythrocytes or fibroblasts.

J Pharmacol Exp Ther. 1996 Jun;277(3):1719-25.

Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action.

Cancer. 1989 Mar 1;63(5):901-6. doi: 10.1002/1097-0142(19890301)63:5<901::aid-cncr2820630518>3.0.co;2-g.

[Selective thermosensitization of mouse Ehrlich ascites tumor cells by diethylstilbestrol].

Z Naturforsch B. 1968 Mar;23(3):350-6.

Synergistic antitumour activity of vitamins C and K3 against human prostate carcinoma cell lines.

Cell Biol Int. 1996 Dec;20(12):787-97. doi: 10.1006/cbir.1996.0102.

引用本文的文献

Anticancer Effects of Ascorbic Acid: Not All Sides Fit All.

Cancers (Basel). 2025 Sep 1;17(17):2877. doi: 10.3390/cancers17172877.

Connection between nutrition and oncology in dogs and cats: perspectives, evidence, and implications-a comprehensive review.

Front Vet Sci. 2025 Feb 18;11:1490290. doi: 10.3389/fvets.2024.1490290. eCollection 2024.

Review of the Potential Role of Ascorbate in the Prevention and Treatment of Gynecological Cancers.

Antioxidants (Basel). 2024 May 19;13(5):617. doi: 10.3390/antiox13050617.

High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines.

Gynecol Oncol. 2024 Apr;183:93-102. doi: 10.1016/j.ygyno.2024.03.021. Epub 2024 Mar 30.

Cancer Metabolism as a Therapeutic Target and Review of Interventions.

Nutrients. 2023 Oct 1;15(19):4245. doi: 10.3390/nu15194245.

Exogenous iron impairs the anti-cancer effect of ascorbic acid both in vitro and in vivo.

J Adv Res. 2023 Apr;46:149-158. doi: 10.1016/j.jare.2022.06.011. Epub 2022 Jun 29.

High-Dose Vitamin C in Advanced-Stage Cancer Patients.

Nutrients. 2021 Feb 26;13(3):735. doi: 10.3390/nu13030735.

Dual Oxidase-Induced Sustained Generation of Hydrogen Peroxide Contributes to Pharmacologic Ascorbate-Induced Cytotoxicity.

Cancer Res. 2020 Apr 1;80(7):1401-1413. doi: 10.1158/0008-5472.CAN-19-3094. Epub 2020 Feb 10.

Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations.

Oxid Med Cell Longev. 2019 Dec 24;2019:7286737. doi: 10.1155/2019/7286737. eCollection 2019.

Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells in vitro.

Cancers (Basel). 2020 Jan 2;12(1):122. doi: 10.3390/cancers12010122.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验